CCND1 and neoplasm: When the impact of cyclin D1 localisation on proliferation was examined (Figure 4C), a statistically significant (P<0.01) difference was identified between predominately cytoplasmic cyclin D1 (4.33±0.63) and predominately nuclear cyclin D1 (12.5±2.77) tumours.